X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2087) 2087
Book Review (435) 435
Publication (211) 211
Magazine Article (20) 20
Book / eBook (6) 6
Conference Proceeding (3) 3
Book Chapter (2) 2
Web Resource (2) 2
Government Document (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1981) 1981
index medicus (1874) 1874
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1540) 1540
male (1080) 1080
female (1019) 1019
statins (903) 903
middle aged (883) 883
aged (821) 821
hydroxymethylglutaryl-coa reductase inhibitors - economics (607) 607
risk factors (573) 573
adult (488) 488
cholesterol (435) 435
cardiovascular diseases - prevention & control (396) 396
medicine, general & internal (393) 393
cardiovascular disease (369) 369
cardiac & cardiovascular systems (366) 366
abridged index medicus (362) 362
prevention (360) 360
pharmacology & pharmacy (347) 347
cost-benefit analysis (346) 346
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (333) 333
risk (315) 315
coronary-heart-disease (310) 310
mortality (302) 302
treatment outcome (290) 290
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (284) 284
aged, 80 and over (262) 262
cholesterol, ldl - blood (260) 260
drug therapy (256) 256
cardiovascular diseases (255) 255
simvastatin (248) 248
therapy (244) 244
analysis (237) 237
hypercholesterolemia - drug therapy (236) 236
primary prevention (226) 226
atorvastatin (224) 224
retrospective studies (221) 221
secondary prevention (216) 216
metaanalysis (214) 214
research (205) 205
cardiovascular-disease (204) 204
pravastatin (196) 196
united states (191) 191
cohort studies (188) 188
risk assessment (188) 188
myocardial-infarction (186) 186
anticholesteremic agents - therapeutic use (182) 182
practice guidelines as topic (180) 180
coronary heart disease (175) 175
internal medicine (172) 172
care and treatment (166) 166
coronary disease - prevention & control (166) 166
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (165) 165
lipids (162) 162
hypercholesterolemia (158) 158
cardiovascular agents (157) 157
cardiology (155) 155
health care sciences & services (155) 155
disease (154) 154
drug costs (152) 152
drugs (151) 151
medicine & public health (151) 151
adherence (150) 150
cardiovascular diseases - drug therapy (150) 150
medication adherence (149) 149
statin (147) 147
animals (146) 146
diabetes (144) 144
health aspects (142) 142
atorvastatin calcium (139) 139
studies (139) 139
time factors (139) 139
cardiovascular (132) 132
simvastatin - therapeutic use (131) 131
patient compliance (130) 130
randomized controlled trials as topic (128) 128
cost-effectiveness (123) 123
heart-disease (122) 122
atherosclerosis (121) 121
cardiovascular diseases - epidemiology (121) 121
cholesterol - blood (120) 120
patients (118) 118
anticholesteremic agents - economics (117) 117
cardiovascular diseases - economics (116) 116
angiotensin-converting enzyme inhibitors - therapeutic use (115) 115
events (115) 115
hydroxymethylglutaryl-coa reductase inhibitors (115) 115
usage (113) 113
dyslipidemias - drug therapy (112) 112
medicine (112) 112
dosage and administration (111) 111
follow-up studies (111) 111
heptanoic acids - therapeutic use (111) 111
hypolipidemic agents - therapeutic use (111) 111
management (111) 111
peripheral vascular disease (111) 111
pyrroles - therapeutic use (111) 111
hyperlipidemias - drug therapy (108) 108
platelet aggregation inhibitors - therapeutic use (108) 108
age factors (106) 106
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2043) 2043
German (20) 20
French (10) 10
Spanish (10) 10
Italian (7) 7
Russian (5) 5
Dutch (4) 4
Swedish (4) 4
Turkish (3) 3
Finnish (2) 2
Portuguese (2) 2
Chinese (1) 1
Danish (1) 1
Japanese (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10013, pp. 61 - 69
Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible... 
Internal Medicine | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Index Medicus | Abridged Index Medicus | Klinisk medicin | Clinical Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 22, pp. 2088 - 2097
Journal Article
Circulation, ISSN 0009-7322, 07/2011, Volume 124, Issue 2, pp. 146 - 153
Journal Article
2006, Routledge international studies in health economics, ISBN 0415701457, x, 139
Book
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, pp. e0169761 - e0169761
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 08/2017, Volume 177, Issue 8, pp. 1093 - 1101
Journal Article
Journal Article